Prognostic factors in colorectal cancer

Hepato-Gastroenterology

Volumn 47, Issue 32, 2000, Pages 310-314

  Gennari, Leandro ^a   Doci, Roberto ^a   Rossetti, Carlo ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Biological factors; Colorectal cancer; Prognosis

Indexed keywords

COLORECTAL CANCER; HUMAN; INTESTINE WALL; LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT PLANNING;

COLORECTAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034004377     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. 1 Jass JR, Atkin WS, Cuzick I: The grading of rectal cancer: histological perspectives and a multivariate analysis of 447 cases. Histopathology 1986; 10:437-459.
2. 2 Heimann TM, Oh C, Aufses AH: Clinical significance of rectal cancer in young patients. Dis Colon Rectum 1989; 32:473-476.
3. 3 Smith C, Butler JA: Colorectal cancer in patients younger than 40 years of age. Dis Colon Rectum 1989; 32:843-846.
4. 4 Jessup JM: Cancer of the colon, rectum and anus. In: Cohen AM, Winawer LL (Eds.). Mc Graw-Hill, 1995; pp. 217-224.
5. 5 Payne JE, Chapuis PH, Pheils MT: Surgery for large bowel cancer in people aged 75 years and older. Dis Colon Rectum 1986; 29:733-737.
6. 6 Kune GA, Kune S, Field B, et al: Survival in patients with large-bowel cancer. Dis Colon Rectum 1990; 33:938-946.
7. 7 Crucitti F, Sofo L, Doglietto GB, et al: Prognostic factors in colorectal cancer: Current status and new trends. J Surg Oncol 1991; (Suppl 2):76-82.
8. 8 Steinberg SM, Barkin JS, Kaplan RS, et al: Prognostic indicators of colon tumors: The Gastrointestinal Tumor Group experience. Cancer 1986; 57:1866-1870.
9. 9 Chapius PH, Dent OF, Fisher R, et al: A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985; 72:698-702.
10. 10 Griffin MR, Bergstralh EJ, Coffey RJ, et al: Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 1987; 60:2318-2324.
11. 11 Seinberg SM, Barkin JS, Kaplan RS, et al: Prognostic indicators of colon tumors: The Gastrointestinal Tumor Group experience. Cancer 1986; 57:1866-1870.
12. 12 Cappell MS, Goldberg ES: The relationship between the clinical presentation and spread of colon cancer in 315 consecutive patients: A significant trend of earlier cancer detection from 1982 through 1988 at a university hospital. J Clin Gastroenterol 1992; 14:227-235.
13. 13 Crucitti F, Sofo L, Doglietto GB, et al: Prognostic factors in colorectal cancer: current status and new trends. J Surg Oncol 1991; (suppl 2):76-82.
14. 14 Garcia-Valdescasas JC, Lovera JM, deLacy AM, et al: Obstructing colorectal carcinomas: prospective study. Dis Colon Rectum 1991; 34:759-762.
15. 15 Kune GA, Kune S, Field B, et al: Survival in patients with large bowel cancer. Dis Colon Rectum 1990; 33:938-946.
16. 16 Heald RJ, Ryall RD: Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1:(8496):1479-1482.
17. 17 Arbman G, Nilsson E, Hallbook O, Sjodahl R: Local recurrence following total mesorectal excision for rectal cancer. Br J Surg 1996; 83:375-379.
18. 18 Enker WE, Thaler HT, Cranor ML, Polyak T: Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181:335-346.
19. 19 Hida J, Yasutomi M, Maruyama T, Fujimoto K, Uchida T, Okuno K: Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. J Am Coll Surg 1997; 184:584-588.
20. 20 Choi JS, Kim SJ, Kim YI, Min JS: Nodal metastasis in the distal mesorectum: need for total mesorectal excision of rectal cancer. Yonsei Med J 1996; 37(4):243-250.
21. 21 Hermanek P, Sobin LH: Carcinoma colorettale. In: UICC Fattori Prognostici in Oncologia (Ed.). Turin: Minerva Medica, 1997;pp. 64-79.
22. 22 Adell G, Boeryd B, Franklund B, Sjodahl R, Hakansson L: Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes B colorectal carcinoma: an immunohistochemical study. Eur J Surg 1996; 162:637-642.
23. 23 Willett CG, Lewandrowski K, Donnelly S: Are there patients with stage I rectal carcinoma at risk for failure after abdominoperineal resection? Cancer 1992; 69:1651-1655.
24. 24 Minsky BD, Mies C, Recht A, et al: Resectable adenocarcinoma of the rectosigmoid and rectum: II° The influence of blood vessel invasion. Cancer 1988; 61:1417-1424.
25. 25 Horn A, Dahl O, Morild I: The role of venous and neural invasion on survival in rectal adenocarcinoma. Dis Colon Rectum 1990; 33:598-601.
26. 26 Knudsen JB, Nilsson T, Splechler M, et al: Venous and nerve invasion as prognostic factors in postoperative survival of patients with resectable cancer of the rectum. Dis Colon Rectum 1983; 26:613-617.
27. 27 Takahashi T, Kato T, Kodaira S, Koyama Y, Sakabe T, Tominaga T, Hamano K, Yasutomi M, Ogawa N: Prognostic factors of colorectal cancer. Results of multivariate analysis of curative resection cases with or without chemotherapy. Am J Clin Oncol 1996; 19:408-415.
28. 28 Harrison LE, Guillem JG, Paty P, Cohen AM: Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients. J Am Coll Surg 1997; 185(1):55-59.
29. 29 Rustum YM, Harstrick A, Cao S, et al: Thymidylate synthase inhibitors in cancer therapy: Direct and indirect inhibitors. J Clin Oncol 1997; 15:389-400.
30. 30 Leichman L, Lenz H-J, Leichman CG, et al: Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: Preliminary report from an ongoing trial. Eur J Cancer 1995; 31A(7/8):1306-1310.
31. 31 Machover D: Developments of the fluoropyrimidines as inhibitors of thymidylate synthetase: Pharmacologic and clinical aspects. J Surg Oncol 1991; (Suppl 2):42-50.
32. 32 Cho KR, Vogelstein B: Genetic alterations in the adenoma carcinoma sequence. Cancer 1992; 70:1727-1731.
33. 33 Kimura O, Sugamura K, Kijima T, Makino M, Shirai H, Tatebes, Ito H, Kaibara N: Flow cytometric examination of p53 protein in primary tumors and metastases to the liver and lymph nodes of colorectal cancer. Dis Colon Rectum 1996; 39:1422-1428.
34. 34 Heide I, Thiede C, Sonntag T, de Jant E, Neubauer A, Jonas S, et al: The status of p53 in the metastatic progression of colorectal cancer. Eur J Cancer 1997; 33:1314-1322.
35. 35 Mosnier JF, Perret AG, Vindimian M, Dumollard JM, Balique JG, Perpoint B, Boucheron S: An immunohistochemical study of simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum. Arch Pathol Lab Med 1996; 120:654-659.
36. 36 Sory A, Minamoto T, Ohta T, et al: Does p53 overexpression cause metastases in early invasive colorectal adenocarcinoma? Eur J Surg 1997; 163:685-692.
37. 37 Gandolfo GM, Conti L, Vercillo M: Fibricolysis components as prognostic markers in breast cancer and colorectal carcinoma. Anticancer Res 1996; 16:2155-2159.
38. 38 Ropponen KM, Eskelinen ML, Lipponen PK, et al: Prognostic value of tumor-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 1997; 182(3):318-324.
39. 39 Ambiru S, Miyazaki M, Ito H, et al: A prospective study of prognostic value of type IV callagenase activity in colorectal cancer tissue. Dig Dis Sci 1997; 42(8):1660-1665.